CTRI/2023/07/055119Not yet recruitingUnknown
To evaluate the role of 1,3-Beta-D-Glucan for diagnosing invasive fungal infections in adults in ICU- a prospective observational study - Nil
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1)Candida Score >3 for Invasive Candidiasis OR
- •2)Fulfilling Meersseman criteria for Invasive Aspergillosis
Exclusion Criteria
- •1)Patients < 18 years
- •2)Patients already on antifungal treatment
- •3)Unwillingness to participate in study
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis PneumoniaJPRN-UMIN000014818ational Center for Global Health and Medicine180
Not yet recruiting
Unknown
sefulness of Beta-D Glucan (BDG) test in the treatment of fungal diseases in intensive care setupCTRI/2023/07/055921Apollo Hospitals
Unknown
Phase 2
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic SyndromeCardiometabolic SyndromeNCT05079529University of Brawijaya70
Terminated
Not Applicable
The potential of beta-glucan intake in the prevention of viral diseases.influenza and norovirus-related gastroenteritisJPRN-UMIN000020660Kochi University80
Completed
Not Applicable
The effect of Beta Glucan and both of Beta Glucan and Lactobacillus Rhamnosus GG on immune system , nutritional status and side effects of chemptherapy in breast cancer patientsBreast Cancer.Malignant Neoplasm of BreastIRCT201212172017N10Hematology Oncology Research Center, Tabbriz University of medical Sciences45